Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers

This publication has 14 references indexed in Scilit:

• Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1992
• Severe malaria in Gambian children is not due to lack of previous exposure to malaria
  Clinical and Experimental Immunology, 1992
• Comparison of antibody responses to the circumsporozoite protein repeat region and to intact sporozoites during acute falciparum malaria
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1989
• Naturally Acquired Antibodies to Sporozoites Do Not Prevent Malaria: Vaccine Development Implications
  Science, 1987
• Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.
  Journal of Clinical Investigation, 1987
• Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
  Nature, 1987
• SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE
  The Lancet, 1987
• Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.
  The Journal of Experimental Medicine, 1983
• Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.
  The Journal of Experimental Medicine, 1980
• Prepatent periods of a tropical strain of Plasmodium vivax after inoculations of tenfold dilutions of sporozoites
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1976